UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Blood, 2013-01, Vol.121 (3), p.537-545

2013

Volltextzugriff (PDF)

Prothrombin Complex Concentrate for Vitamin K Antagonist-Associated Intracranial Hemorrhage　― Global Evidence and the Japanese Perspective

Circulation Journal, 2017/10/25, Vol.81(11), pp.1564-1573

2017

Volltextzugriff (PDF)

Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia

The New England journal of medicine, 2012-08, Vol.367 (8), p.716-724

2012

Volltextzugriff (PDF)

Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study

International journal of hematology, 2017-12, Vol.106 (6), p.777-786

2017

Volltextzugriff (PDF)

Coagulation Factor Plasma Levels Following Administration of a 4-Factor Prothrombin Complex Concentrate for Rapid Vitamin K Antagonist Reversal in Japanese Patients

Current therapeutic research, 2018-01, Vol.89, p.21-26

2018

Volltextzugriff (PDF)

A Randomized, Open-Label, 5-Period, Balanced Crossover Study to Evaluate the Relative Bioavailability of Eltrombopag Powder for Oral Suspension (PfOS) and Tablet Formulations and the Effect of a High-Calcium Meal on Eltrombopag Pharmacokinetics When Administered With or 2 Hours Before or After PfOS

Clinical therapeutics, 2012-03, Vol.34 (3), p.699-709

2012

Volltextzugriff (PDF)

Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Randomized Controlled Trials

Emergency medicine international, 2017-01, Vol.2017, p.8024356-8

2017

Volltextzugriff (PDF)

Thromboembolic Events Observed in Eltrombopag Clinical Trials in Chronic Immune Thrombocytopenic Purpura

Blood, 2009-11, Vol.114 (22), p.2423-2423

2009

Volltextzugriff (PDF)

Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag

Platelets (Edinburgh), 2015-01, Vol.26 (1), p.93-96

2015

Volltextzugriff (PDF)

Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia

Quality of life research, 2011-12, Vol.20 (10), p.1737-1744

2011

Volltextzugriff (PDF)

Hemostatic challenges in patients with chronic immune thrombocytopenia treated with eltrombopag

Platelets (Edinburgh), 2014-01, Vol.25 (1), p.55-61

2014

Volltextzugriff (PDF)

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children < 12 Years of Age with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Blood, 2017-12, Vol.130, p.2370-2370

2017

Volltextzugriff (PDF)

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Adolescents/Adults with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Blood, 2017-12, Vol.130, p.3690-3690

2017

Volltextzugriff (PDF)

Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy

Gastroenterology (New York, N.Y. 1943), 2014-02, Vol.146 (2), p.442-452.e1

2014

Volltextzugriff (PDF)

Interim Analysis of the Extension Study with rVIII-SingleChain in Previously Untreated Patients (PUPs) with Severe Hemophilia A (CSL627-3001)

Blood, 2019-11, Vol.134 (Supplement_1), p.162-162

2019

Volltextzugriff (PDF)

Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis

Autoimmunity reviews, 2016-03, Vol.15 (3), p.203-209

2016

Volltextzugriff (PDF)

Baseline Laboratory Parameters Potentially Associated with Thrombophilia in Patients with Chronic ITP

Blood, 2012-11, Vol.120 (21), p.2191-2191

2012

Volltextzugriff (PDF)

Fibrinogen concentrate for bleeding in patients with congenital fibrinogen deficiency: Observational study of efficacy and safety for prophylaxis and treatment

Research and practice in thrombosis and haemostasis, 2020-11, Vol.4 (8), p.1313-1323

2020

Volltextzugriff (PDF)

Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia

Current medical research and opinion, 2012-01, Vol.28 (1), p.79-87

2012

Volltextzugriff (PDF)

4-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: 930

The American journal of gastroenterology, 2016-10, Vol.111, p.S402-S403

2016

Volltextzugriff (PDF)

A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”

PharmacoEconomics, 2013-01, Vol.31 (1), p.87-89

2013

Volltextzugriff (PDF)

Cumulative Response to Eltrombopag and Impact of the Number of Prior ITP Therapies: Interim Results of a Long-Term Extension Study

Blood, 2011-11, Vol.118 (21), p.3297-3297

2011

Volltextzugriff (PDF)

Rate of Cataracts Across the Eltrombopag Clinical Studies in Patients with Chronic Immune Thrombocytopenia

Blood, 2011-11, Vol.118 (21), p.1164-1164

2011

Volltextzugriff (PDF)

Thrombophilia in patients with chronic immune thrombocytopenia

Scandinavian journal of clinical and laboratory investigation, 2015-01, Vol.75 (1), p.13-17

2015

Volltextzugriff (PDF)

Thrombosis in Immune Thrombocytopenia Patients with Antiphospholipid Antibodies: A Meta-Analysis

BLOOD, 2015-12, Vol.126 (23), p.1051-1051

2015

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(49)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Humans
(14)
Female
(9)
Male
(9)
Adult
(8)
Chronic Disease
(8)
Middle Aged
(8)
Aged
(7)
Benzoates - Therapeutic Use
(7)
Hematology
(7)
Hydrazines - Therapeutic Use
(7)
Pyrazoles - Therapeutic Use
(7)
Adolescent
(6)
Aged, 80 And Over
(6)
Platelet Count
(6)
Receptors, Thrombopoietin - Agonists
(6)
Bleeding
(5)
Medicine
(5)
Surgery
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Prothrombin Complex Concentrate for Vitamin K Antagonist-Associated Intracranial Hemorrhage　― Global Evidence and the Japanese Perspective

Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia

Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study

Coagulation Factor Plasma Levels Following Administration of a 4-Factor Prothrombin Complex Concentrate for Rapid Vitamin K Antagonist Reversal in Japanese Patients

A Randomized, Open-Label, 5-Period, Balanced Crossover Study to Evaluate the Relative Bioavailability of Eltrombopag Powder for Oral Suspension (PfOS) and Tablet Formulations and the Effect of a High-Calcium Meal on Eltrombopag Pharmacokinetics When Administered With or 2 Hours Before or After PfOS

Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Randomized Controlled Trials

Thromboembolic Events Observed in Eltrombopag Clinical Trials in Chronic Immune Thrombocytopenic Purpura

Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag

Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia

Hemostatic challenges in patients with chronic immune thrombocytopenia treated with eltrombopag

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Children < 12 Years of Age with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (RIX-FP) in Previously Treated Adolescents/Adults with Hemophilia B: Long-Term Efficacy and Safety from an Ongoing Phase 3b Extension Clinical Trial

Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy

Interim Analysis of the Extension Study with rVIII-SingleChain in Previously Untreated Patients (PUPs) with Severe Hemophilia A (CSL627-3001)

Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis

Baseline Laboratory Parameters Potentially Associated with Thrombophilia in Patients with Chronic ITP

Fibrinogen concentrate for bleeding in patients with congenital fibrinogen deficiency: Observational study of efficacy and safety for prophylaxis and treatment

Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia

4-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: 930

A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”

Cumulative Response to Eltrombopag and Impact of the Number of Prior ITP Therapies: Interim Results of a Long-Term Extension Study

Rate of Cataracts Across the Eltrombopag Clinical Studies in Patients with Chronic Immune Thrombocytopenia

Thrombophilia in patients with chronic immune thrombocytopenia

Thrombosis in Immune Thrombocytopenia Patients with Antiphospholipid Antibodies: A Meta-Analysis

Suchergebnisse filtern